Tenaya Therapeutics Inc

-0.19 (-3.38%)

Tenaya Therapeutics Launches Operations Of New Genetic Medicines Manufacturing Center To Support Development Of Potentially First-In-Class Cardiovascular Therapeutics

Published: 06/16/2022 12:13 GMT
Tenaya Therapeutics Inc (TNYA) - Tenaya Therapeutics Launches Operations of New Genetic Medicines Manufacturing Center to Support the Development of Potentially First-in-class Cardiovascular Therapeutics.
Tenaya Therapeutics Inc - Facility to Provide Clinical Supply of Lead Gene Therapy Programs Tn-201 and Tn-401 for Planned First-in-human Studies.
Tenaya Therapeutics Inc - Facility Has Initial Production Capacity at 1000l Scale.